Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/29/2008 | EP1984014A1 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia |
10/29/2008 | EP1984012A2 Use of peptidic vasopressin receptor agonists |
10/29/2008 | EP1984011A2 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
10/29/2008 | EP1984010A2 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
10/29/2008 | EP1984009A2 Pharmaceutical compositions with enhanced stability |
10/29/2008 | EP1984008A2 Ace n-domain crystal |
10/29/2008 | EP1983930A2 Drug delivery system for retarding release of water soluble drugs |
10/29/2008 | EP1983849A1 A food composition comprising amino acids |
10/29/2008 | EP1809238B1 Ophthalmic emulsions containing an immunosuppressive agent |
10/29/2008 | EP1729796B1 Pressure sore treatment |
10/29/2008 | EP1710251B1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
10/29/2008 | EP1668129B1 Anti-angiogenic peptides from the n-terminus of endostatin |
10/29/2008 | EP1619208B1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein |
10/29/2008 | EP1589986B1 Methods and uses of the integrin alpha 10 chain, for diagnosing and detecting atherosclerosis plaque formation in vitro |
10/29/2008 | EP1562979B1 Tubulysins, method for producing the same and tubulysin preparations |
10/29/2008 | EP1556141B1 Method for the prophylaxis and therapy of mycoses in fish and invertebrates and the development stages thereof |
10/29/2008 | EP1487285B9 Alertness bar |
10/29/2008 | EP1474164B1 Use of amylin, amylin analogs and amylin derivatives to treat dyslipidemia and triglyceridemia |
10/29/2008 | EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease |
10/29/2008 | EP1424077B1 Insulin-containing oral spray and the preparation method thereof |
10/29/2008 | EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns |
10/29/2008 | EP1370697B1 Peroxiredoxin drugs for treatment of hiv-1 infection |
10/29/2008 | EP1334119B1 Compositions and methods for modulating rsv infection and immunity |
10/29/2008 | EP1317256B1 Pharmaceutical composition having modified carrier |
10/29/2008 | EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis |
10/29/2008 | EP1278868B9 Mutated form of arginine deiminase |
10/29/2008 | EP1278574B1 Topical composition for the treatment of psoriasis and related skin disorders |
10/29/2008 | EP1255560B1 Cd40 ligand adjuvant for respiratory syncytial virus vaccine |
10/29/2008 | EP1222208B1 Polypeptide derivatives of parathyroid hormone (pth) |
10/29/2008 | EP1208217B1 Antibody dependent enhancement (ade) of alphavirus infection |
10/29/2008 | EP1196607B1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
10/29/2008 | EP1156823B1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
10/29/2008 | EP1144592B1 Substrate for cell growth |
10/29/2008 | EP1116791B1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
10/29/2008 | EP1076564B1 Compositions for enhancing antigen-presenting cells and anti-tumor responses in a human patient |
10/29/2008 | EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES |
10/29/2008 | EP1054693B1 Inhibitors of complement activation |
10/29/2008 | EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
10/29/2008 | EP0961831B1 Human endokine alpha |
10/29/2008 | EP0898580B3 Methods and means for inhibition of cdk4 activity |
10/29/2008 | EP0846128B1 Antimicrobial cationic peptides and methods of screening for the same |
10/29/2008 | EP0752872B1 Nadh oxidase as a target in diagnosis and therapy |
10/29/2008 | EP0695351B2 Isolation, selection and propagation of animal transgenic stem cells other than embryonic stem cells |
10/29/2008 | EP0660721B1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells |
10/29/2008 | CN101297034A Ply-gbs突变溶素 Ply-gbs mutant lysin |
10/29/2008 | CN101297033A Debriding composition from bromelain and methods of production thereof |
10/29/2008 | CN101296708A 选择性vpac2受体肽激动剂 Vpac2 receptor selective agonist peptide |
10/29/2008 | CN101296704A Methods for reducing CD36 expression |
10/29/2008 | CN101296692A Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system |
10/29/2008 | CN101294187A Method for sustained-releasing polypeptide with biological activity and application thereof |
10/29/2008 | CN101293929A Preparation and application of natural polypeptide medicaments derivative |
10/29/2008 | CN101293928A Preparation and application of genetic engineering synthetic polypeptide medicaments for treating tubercle bacillus infection contamination |
10/29/2008 | CN101293927A Preparation and application of artificial synthetic polypeptide medicaments for treating tubercle bacillus infection contamination |
10/29/2008 | CN101293926A Preparation and application of antimicrobial peptide medicaments for treating tubercle bacillus infection contamination |
10/29/2008 | CN101293925A Preparation and application of synthetic polypeptide medicaments for treating tubercle bacillus infection contamination |
10/29/2008 | CN101293091A Preparation technique for hepatocyte growth promoting factors |
10/29/2008 | CN101293090A Application of Exenatide in preparing medicament for reversing activation of FFA to P53 |
10/29/2008 | CN101293089A Method for preparing phaescolosaxin oral administration dosage form |
10/29/2008 | CN101293088A Medicament for treating rectum cancer and stomach cancer |
10/29/2008 | CN101292951A Recombined human vascellum esoderma inhibin durative action preparation, preparation method and application thereof |
10/29/2008 | CN100429233C Recombinant solvent protein, its production and use |
10/29/2008 | CN100429232C Vaughan Tristan J. |
10/29/2008 | CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor |
10/29/2008 | CN100429229C Jingzhao toxin V |
10/29/2008 | CN100429228C Recombination human A20 protein and its uses |
10/29/2008 | CN100429227C Exendin 4 polypeptide segment |
10/29/2008 | CN100429225C Promyostatin peptides and methods of using same |
10/29/2008 | CN100429224C Antitumor activity of squash protein and use thereof |
10/29/2008 | CN100428958C Implant agent for treating ophthalmopathy |
10/29/2008 | CN100428955C Composition of protective agent for radiation damage |
10/29/2008 | CN100428954C Vaginal effervescence tablet of interferon and its preparation method |
10/29/2008 | CN100428938C Glucocorticoid capsule type inhaling atomized powder and preparation method |
10/29/2008 | CN100428936C 抗病毒化合物 Antiviral compounds |
10/28/2008 | USRE40555 Preparation of agarose coated, solid agarose beads containing secretory cells |
10/28/2008 | US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors |
10/28/2008 | US7442788 Nucleosides; peptide nucleic acids; orientation of sugar governs positioning of antisense molecule |
10/28/2008 | US7442784 For regulation of gene expression |
10/28/2008 | US7442783 Natural IgM antibodies and inhibitors thereof |
10/28/2008 | US7442781 Diagnosis, prevention and treatment of cancer |
10/28/2008 | US7442767 α1D calcium channel expressed in atrium |
10/28/2008 | US7442764 Reversible modification of amine-containing compounds |
10/28/2008 | US7442763 Kidney diseases |
10/28/2008 | US7442720 concurrent administration of cysteamine hydrochloride with metformin |
10/28/2008 | US7442711 Amelioration of the development of cataracts and other ophthalmic diseases |
10/28/2008 | US7442695 Depeptidized inhibitors of hepatitis C virus NS3 protease |
10/28/2008 | US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation |
10/28/2008 | US7442686 Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions |
10/28/2008 | US7442684 A hormone or growth factor subunit and a half-life-increasing moiety are covalently bound; increasing fertility, egg production, spermatogenesis and vascularization; especially VEGF-FSH with increased serum half lives |
10/28/2008 | US7442683 For use as antifungal agent |
10/28/2008 | US7442682 disclosed for the treatment of diabetes and related diseases using peptides with incretin hormone activity. Preferably, the peptide with incretin hormone activity is GLP-1, exendin or an analog of GLP-1 or exendin. The peptides with incretin hormone activity are administered transepithelially hormones |
10/28/2008 | US7442681 regulating vascular permeability. A peptide inhibitor of p21-activated kinase has been found to inhibit the increase in vascular permeability induced by several factors. The present invention further provides methods of identifying regulators of vascular permeability. |
10/28/2008 | US7442680 Inotropic and diuretic effects of GLP-1 and GLP-1 agonists |
10/28/2008 | US7442550 Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation; use in drug testing or drug screening; HERV-W envelope glycoprotein; cancer gene therapy |
10/28/2008 | US7442547 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
10/28/2008 | US7442546 Method of modulating inflammatory response |
10/28/2008 | US7442543 Nucleotide sequences coding selenium containing protein for use in diagnosis, prevention and treatment prostate cell proliferative disorders |
10/28/2008 | US7442526 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide |
10/28/2008 | US7442524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
10/28/2008 | US7442520 modulator of tumor growth and metastasis in certain cancer types, especially breast and lung cancer |
10/28/2008 | US7442513 Method of screening for agents that modulate a homer signaling pathway |